Bacil Pharma Ltd.
| BSE: 524516 | Sector: Health care |
| NSE: N.A. | ISIN Code: INE711D01018 |
| BSE 00:00 | 13 Apr | 3.96 |
0 (0.00%) |
OPEN
3.96 |
HIGH
3.96 |
LOW
3.95 |
| NSE 05:30 | 01 Jan | Bacil Pharma Ltd |
| OPEN | 3.96 |
| PREVIOUS CLOSE | 3.96 |
| VOLUME | 809 |
| 52-Week high | 6.12 |
| 52-Week low | 1.57 |
| P/E | |
| Mkt Cap.(Rs cr) | 2 |
| Buy Price | 0.00 |
| Buy Qty | 0.00 |
| Sell Price | 0.00 |
| Sell Qty | 0.00 |
Bacil Pharma Ltd. (BACILPHARMA) - Company Information
Bacil Pharma Ltd
Incorporated as a private limited company in Maharashtra in May '87 Bacil Pharma (BPL) was converted into a public limited company in Oct.'90. BPL came out with a public issue of Rs 7 cr in Mar.'94 to set up a plant at Vapi to manufacture bulk drugs like atenalol norfloxacin pefloxacin and ciprofloxacin. The comapany entered into a marketing arrangement with a distributor Kam Han Industries Hong K...> More
| COMPANY INFORMATION | |||||||
| Independent Director : | Shirish Shetye | ||||||
| Director : | Prakash Shah | ||||||
| Independent Director : | Lalit Jain | ||||||
| Director : | Sneha Shah | ||||||
| Company Secretary : | Vaishali Vaghasiya | ||||||
| AUDITOR : | Laxmikant Kabra & Co | ||||||
| IND NAME : | Pharmaceuticals - Indian - Bulk Drugs | ||||||
| HOUSE NAME : | Indian Private | ||||||
| Registered office | |||||||
| 71 Laxmi Building, Sir P M Road Fort,Mumbai,Maharashtra-400001 | |||||||
| Ph : 91-022-22618452 | |||||||
| WEBSITE : http://www.bacilpharma.com | |||||||
| E-mail : bacilpha@yahoo.com | |||||||
Quick Links for Bacil Pharma:
-
News
Announcements Brokerage Reports Business Earnings Sector -
Corporate Action
AGM Board Meetings Bonus Dividends EGM Rights Split -
INFORMATION
Bulk Deals Company History MF Holding Listing Info Locations Shareholding -
Financials
Financial Overview Balance Sheet Profit & Loss Cash Flow Ratios Quarterly Results Half Yearly Results Nine Monthly Results Yearly Results -
Annual Report
Auditors Report Chairman's Speech Company Management Directors' Report Finished Goods Raw Materials -
Peer Comparison
Competition Market Cap Price Price Performance Net Sales Net Profit Total Assets Historical Prices
